Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Ongoing HTAs of medical technologies in Uppsala-Örebro region in Sweden

In Sweden, the County Councils are grouped into six healthcare regions to facilitate cooperation and to maintain a high level of advanced medical care. One of them is Örebro County Council with its Centre for Assessment of Medical Technology (CAMTÖ).This center serving the whole of Örebro County Council, commissioned to promote Evidence Based Medicine and to act as an advisory body within the County Council in matters related to Health Technology Assessment. It initiates processes to distribute the conclusions of national or regional systematic literature reviews to healthcare through the Council for Medical Knowledge Management. It produces systematic literature reviews for decision making, for example on introducing new methods, or disposal of existing methodology. It leads the development of HTA cooperation in healthcare region Uppsala-Örebro.

Currently, CAMTÖ is working on several assessments related to medical devices and procedures:

  • Medical devices:
    • Equipment for 3D Printing
    • Operation robot Intuitive daVinci Xi
    • Excessive sweat treatment miraDry
    • Hydrogen-methane breath analyzer (QuinTron Breath Testing)
    • Flexible robot for endoscopic surgery in the head and neck area
    • System for vaginal ultrasound probe disinfection
  • Medical procedures:
    • Treatment of rectus diastasis
    • Endoscopic thyroidectomy

After the completion of assessment procedure, the reports are published here.

See the full information in Swedish here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.